$ Value
$0
Shares
2,518
Price
$0
Filed
Jun 12
Insider
Name
BRAWLEY OTIS W
Title
—
CIK
0001213029
Roles
Transaction Details
Transaction Date
2025-06-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
11,252
Footnotes
This award of restricted stock units ("RSUs") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including this grant, this includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. | This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan).
Filing Info
BRAWLEY OTIS W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-11 | PDSB | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-05-15 | LYEL | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |